Intelligence / Healthtech / PMA Approvals / Boston Scientific Corporation
Approvalsdevice change approved (PMA)21 Aug 2026
Boston Scientific Corporation
21 Aug 2026: Device change approved (PMA) · TheraSphere. Recorded in the openFDA device PMA data.
- Decided
- 21 Aug 2026
- Device
- TheraSphere
- Specialty
- Radiology
- Type
- Supplement (Normal 180 Day Track No User Fee)
- Reason
- Postapproval Study Protocol
- Reference
- P200029 S014
- Location
- Marborough, MA
What this signal means
A PMA approval is a high-risk device launch: reimbursement, distribution, clinical training and sales hires follow.
- Cardiovascular leads with 53 of 120, then Pathology (15).
- 35 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at Boston Scientific Corporation
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
Across AOS Research
Other records for Boston Scientific Corporation in our registers.
11 SeptBoston Scientific Corporationdevice cleared · HealthtechApprovals3 SeptBoston Scientificdevice cleared · HealthtechApprovals26 AugBoston Scientific Corporationdevice cleared · HealthtechApprovals21 AugBoston Scientificdevice cleared · HealthtechApprovals12 AugBoston Scientificdevice cleared · HealthtechApprovals15 OctBoston Scientific Corpdevice change approved (PMA) · HealthtechApprovals17 SeptBoston Scientificdevice change approved (PMA) · HealthtechApprovals13 SeptBoston Scientific Corpdevice change approved (PMA) · HealthtechApprovals9 SeptBoston Scientific Corpdevice change approved (PMA) · HealthtechApprovals21 OctBoston Scientific CorporationClass II recall · HealthtechQuality30 SeptBoston Scientific CorporationClass I recall · HealthtechQuality23 SeptBoston Scientific CorporationClass II recall · HealthtechQuality
Source: openFDA device PMA data, data to 18 Nov 2026. Class III devices approved by FDA: original approvals and supplements that change the device (180-day, panel-track and special tracks). 30-day manufacturing notices are left out. AOS shows what the public record says; it does not verify or endorse the company.